- Browse by Subject
Browsing by Subject "Patient Safety"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Ambulatory Computerized Provider Order Entry and PDA-Based Clinical Decision Support Systems: An Investigation of their Patient Safety Effectiveness via an Integrative and Systematic ReviewTaffel, Jared Ross; Jones, Josette F.Substantial research has been done on inpatient provider order entry systems with varying degrees of clinical decision support. Such studies have examined how these technologies impact patient safety as well as the quality and cost of care. However, given that most medical care and prescriptions are administered in an ambulatory setting, the dearth of research on ACPOE systems is quite astonishing. This knowledge gap demonstrates the need for an integrative and systematic literature review that attempts to assess the research done on computerized patient safety interventions in ambulatory care. This review’s findings provided adequate evidence that ACPOE systems are effective interventions for reducing medication errors. Other evidence further indicated that, in terms of functional capabilities, commercial ACPOE and e-prescribing systems may be catching up with their homegrown counterparts. PDA-based CDSSs were depicted as useful tools for raising adherence to guidelines and inducing safer prescribing. These findings suggest that ACPOE And PDA-based CDS systems show promise for improving safety and healthcare quality in ambulatory settings. ACPOE specifically, tended to have more advanced CDS attributes but, nonetheless, showed more negative results compared to the e-prescribing systems. Close scrutiny should therefore be given to the elements of decision support that ambulatory physicians find most useful.Item GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults(Bioscientifica, 2016-02) Allen, D. B.; Backeljauw, P.; Bidlingmaier, M.; Biller, B. M. K.; Boguszewski, M.; Burman, P.; Butler, G.; Chihara, K.; Christiansen, J.; Cianfarani, S.; Clayton, P.; Clemmons, D.; Cohen, P.; Darendeliler, F.; Deal, C.; Dunger, D.; Erfurth, E. M.; Fuqua, J. S.; Grimberg, A.; Haymond, M.; Higham, C.; Ho, K.; Hoffman, A. R.; Hokken-Koelega, A.; Johannsson, G.; Juul, A.; Kopchick, J.; Lee, P.; Pollak, M.; Radovick, S.; Robison, L.; Rosenfeld, R.; Ross, R. J.; Savendahl, L.; Saenger, P.; Toft Sorensen, H.; Stochholm, K.; Strasburger, C.; Swerdlow, A.; Thorner, M.; Department of Pediatrics, IU School of MedicineRecombinant human GH (rhGH) has been in use for 30 years, and over that time its safety and efficacy in children and adults has been subject to considerable scrutiny. In 2001, a statement from the GH Research Society (GRS) concluded that 'for approved indications, GH is safe'; however, the statement highlighted a number of areas for on-going surveillance of long-term safety, including cancer risk, impact on glucose homeostasis, and use of high dose pharmacological rhGH treatment. Over the intervening years, there have been a number of publications addressing the safety of rhGH with regard to mortality, cancer and cardiovascular risk, and the need for long-term surveillance of the increasing number of adults who were treated with rhGH in childhood. Against this backdrop of interest in safety, the European Society of Paediatric Endocrinology (ESPE), the GRS, and the Pediatric Endocrine Society (PES) convened a meeting to reappraise the safety of rhGH. The ouput of the meeting is a concise position statement.Item Obtaining History with a Language Barrier in the Emergency Department: Perhaps not a Barrier After All(eScholarship Publishing, 2018-11) Litzau, Megan; Turner, Joseph; Pettit, Katie; Morgan, Zachary; Cooper, Dylan; Emergency Medicine, School of Medicine